Michael is a co-founder of Proteorex and leads the company’s Business Development activities. He has deep expertise in the BioPharma sector through his experience in research and academia, venture capital investing, and management consulting.
Mike is currently an Investment Director at Cambridge Innovation Capital, a UK-based Venture Capital Fund investing in IP-rich healthcare and technology businesses.
Previously, he was a Principal in the Toronto office of the Boston Consulting Group and a Core Member of BCG’s Health Care Practice Area. During his time at BCG, he served healthcare clients throughout North America, Europe, and Asia. Prior to joining BCG, Mike was an Investment Analyst and Kauffman Fellow at Oxford Capital Partners, a UK-based venture capital firm. Before Oxford Capital, Mike was an academic researcher in the field of neurobiology. He has authored papers published in a number of leading academic journals including Science.
Mike graduated with a 1st Class Honors degree in Biology from Queen’s University, Canada and earned his DPhil in Zoology from Oxford University where he was the Hope Scholar.